Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 3,129–3,136 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
OpGen Inc. BV100 Infections caused by Carbapenem Resistant Acinetobacter baumannii (CRAB) Phase 2 Intravenous Antibiotic
Opko Health Inc. OPK88004 Benign Prostatic Hyperplasia (BPH) Phase 2b Trial Completed Oral N/A
Opko Health Inc. OPK88003 Obesity and diabetes Phase 2b Trial Completed Subcutaneous Endocrinology
Opko Health Inc. RAYALDEE - (REsCue) Mild-to-moderate COVID-19 Phase 2 Ongoing Oral COVID-19
Opko Health Inc. RAYALDEE Secondary hyperparathyroidism (SHPT) in chronic kidney disease (CKD) - Stage 5 Phase 2 Data Released oral Endocrinology
Opthea Limited Sozinibercept (OPT-302) with Aflibercept - (COAST) Age-related macular degeneration (AMD) Phase 3 Trial Discontinued Intravitreal injection Opthalmic
Opthea Limited Sozinibercept (OPT-302) with Ranibizumab - (ShORe) Wet age-related macular degeneration (AMD) Phase 3 Trial Discontinued Intravitreal injection Opthalmic
OptiNose Inc. XHANCE - (ReOpen2) Chronic sinusitis Phase 3 Ongoing Intranasal Respiratory